Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications-Reference-Cited by-同舟云学术

Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications

Published:2023-10 Issue: Volume:67 Page:108202
ISSN:0734-9750
Container-title:Biotechnology Advances
language:en
Short-container-title:Biotechnology Advances

Author:

Yu Mingjing,Hu Shilong,Tang Biao,Yang Hua,Sun Dongchang

Funder

National Natural Science Foundation of China

Zhejiang University of Technology

Key Research and Development Program of Zhejiang Province

Publisher

Elsevier BV

Subject

Biotechnology,Bioengineering,Applied Microbiology and Biotechnology

Reference172 articles.

1. Large deletions induced by Cas9 cleavage;Adikusuma;Nature,2018

2. Proteomic analysis of outer membrane vesicles from the probiotic strain Escherichia coli Nissle 1917;Aguilera;Proteomics,2014

3. Bacteria-derived minicells for cancer therapy;Ali;Cancer Lett.,2020

4. Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/PTEN signaling pathways;Alizadeh;Iran J. Basic Med. Sci.,2020

5. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction;Alvarez;BMC Microbiol.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system;Applied and Environmental Microbiology;2024-09-10

2. A Simple and Rapid Method of Probiotic Bacterial Ghost Cell Preparation to Deliver Mycobacterium tuberculosis Antigen;Molecular Biotechnology;2024-08-20

3. Development of a Type I-E CRISPR-Based Programmable Repression System for Fine-Tuning Metabolic Flux toward D-Pantothenic Acid in Bacillus subtilis;ACS Synthetic Biology;2024-07-31

4. Coordinated optimization of the polymerization and transportation processes to enhance the yield of exopolysaccharide heparosan;Carbohydrate Polymers;2024-06

5. The feasibility of using pathobiome strains as live biotherapeutic products for human use;iMeta;2024-05-26